MAGI2 and non-small cell lung carcinoma: The combination of MAGI2-AS3 and ZFAS1 demonstrated a superior ability to discriminate between NSCLC and controls, suggesting that these lncRNAs could serve as biomarkers for NSCLC diagnosis [206].